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late G2, a phenotype identical to that observed followingAurora A and Mitotic Commitment
aurA depletion. Moreover, although Aurora A protein
recruitment to centrosomes was apparently normal, the
kinase failed to autophosphorylate and to be activated
on G2 centrosomes, suggesting that the Aurora A/AjubaA remarkable study published in this issue of Cell (Hi-
complex plays a key role during G2/M progression. Inter-rota et al., 2003) reveals a key role of Aurora A protein
estingly, following incubation with Aurora A, Ajuba be-kinase in G2/M progression. To achieve this role, Au-
comes phosphorylated, Aurora A autophosphorylates,rora A acts in conjunction with the LIM protein Ajuba,
and both proteins form a complex. The kinase activitywhich functions as an activating factor.
of the two-protein complex is then strongly enhanced
in vivo and in vitro.Aurora A and B protein kinases are present in various
Overall, therefore, Hirota et al. showed that Aurora Aorganisms and are important factors in mitotic control.
protein kinase and its interacting activator, Ajuba, playAurora B kinase exists in a conserved complex of pro-
key roles in orchestrating mitotic commitment. Giventeins and seems to play a key role in mitotic checkpoint
these results, it does seem surprising that, althoughcontrol, chromosome dynamics, and cytokinesis (Ad-
aurora A function has been examined in several species,ams et al., 2001). Aurora A protein kinases are involved
its major function reported thus far is mitotic spindlein spindle formation. Remarkably, the human aurora A
assembly. For example, the primary defect in the wholegene behaves like an oncogene and is believed to play
Drosophila aurA mutant nervous system is an increasea role in tumor induction in vivo (Bischoff et al., 1998).
in the number of cells with abnormal spindles (GloverAurora A localizes to the centrosomes and spindle and
et al., 1995). It is possible that aurA mutant neuroblastphosphorylates spindle-associated proteins. These
cells can enter mitosis with a slight delay but then be-substrates are known to be involved in spindle formation
come arrested following activation of the metaphaseand stability. Consistent with this, mutation or disruption
checkpoint. In C. elegans, the timing of mitotic entryof the aurora A gene in various species leads to mitotic
is not affected following aurora A RNAi, although theabnormalities, including centrosome separation and
centrosomes do not mature (Hannak et al., 2001). We
maturation defects, spindle aberrations, and chromo-
cannot exclude the possibility that mitotic commitment
some segregation defects. Overall, these data suggest
is species-dependent or that alternative pathways can
that aurora A is an essential regulator of the mitotic
trigger mitosis during the development of whole or-
apparatus (Adams et al., 2001).
ganisms.
However, Aurora A also has other functions. Previous
Nevertheless, it is now clear that Aurora A joins a
studies suggested that Aurora A plays a key role during group of mitotic kinases including Polo, NIMA, and cdk1
Xenopus laevis oocyte maturation (meiotic transition), a that are involved in the G2/M transition. It is important
process by which oocytes become competent for fertil- to note that all of these protein kinases localize to the
ization (Andresson and Ruderman, 1998). Now, a report MTOCs (microtubule organizing centers or centro-
by Hirota et al. (2003) in this issue of Cell shows that somes), suggesting that this organelle is an essential
Aurora A is also required for mitotic entry in human cells. location for regulatory events during the G2/M transition
Using an antibody specific for the activated/phosphory- (Nigg, 2001). It seems that the initial recruitment of mi-
lated form of Aurora A, the authors showed that although totic cyclin B1 to the centrosome and centrosome matu-
Aurora A is recruited onto the centrosome during early ration in general are key steps for mitotic entry.
G2, it only becomes phosphorylated and activated on The mechanism of Aurora A kinase activation is also
centrosomes in late G2 prior to mitosis. Interestingly, in intriguing. The kinase needs Ajuba as a partner to au-
cells where cdk1/cyclinB kinase activity was compro- toactivate and to enhance kinase activity. Interestingly,
mised (using specific kinase inhibitors), the initial activa- both XlAurora A and XlAjuba were found to accelerate
tion of Aurora A by phosphorylation persisted but was meiosis during oocyte maturation, suggesting that the
reduced compared to wild-type cells. This suggests that pathway to enter mitosis and meiosis is conserved
cdk1/cyclin B kinase activity is not required for the initial throughout evolution (Andresson and Ruderman, 1998;
activation of Aurora A at the centrosomes but instead Goyal et al., 1999). The activation of Aurora A by Ajuba
enhances its recruitment and activation as the cells en- is reminiscent of the activation of cdk1 kinase by mitotic
ter mitosis. To investigate whether aurora A is required cyclins. However, a significant difference is that Ajuba
for mitotic commitment, Hirota et al. studied the behav- protein levels do not fluctuate during cell cycle transi-
ior of synchronized human cells following aurora A dis- tions, suggesting that Ajuba protein is essential but not
ruption by RNAi. They found that cells depleted for Au- sufficient to activate Aurora A in vivo. Other regulatory
rora A protein kinase are unable to enter mitosis. mechanisms might ensure that although both proteins
Furthermore, the cells were able to synthesize cyclin B1 are present in the cell, Aurora A kinase activity only
but were unable to recruit it to the centrosomes. becomes enhanced during the G2/M transition.
To elucidate Aurora A regulation at a molecular level, Aurora A has another previously characterized activa-
the authors used a 2-hybrid screen to identify a binding tor, TPX2 (targeting protein for Xklp2) (Tsai et al., 2003).
partner for Aurora A, the LIM protein Ajuba. In the ab- TPX2 remains in the nucleus up to mitotic entry, sug-
gesting that it acts as an Aurora A activator after thesence of Ajuba protein the cells remained arrested in
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start of mitosis. In addition, it has been shown that TPX2 including transcriptional regulation, cell cycle control,
and protein trafficking. More recently, it has been impli-targets Aurora A to spindle microtubules (Kufer et al.,
cated in common ailments such as cancer and neurode-2002). It is possible that Aurora A has multiple partners,
generative disease. It is now rare that a researcher haslocalized either to the centrosome (Ajuba) to activate
to leave far from his field to encounter the trademarkthe kinase during mitotic entry, or on the mitotic spindle
enzymatic cascade of ubiquitylation enzymes E1, E2,(TPX2) to activate the kinase on spindle microtubules.
and E3, but the mechanism by which these enzymesThis leads to the interesting idea that localized pools of
cooperate in the substrate-specific synthesis of polyubi-Aurora A kinase are specifically and locally regulated
quitin chains remains foggy.by various proteins from late G2 to metaphase. Identi-
E3 ubiquitin ligases catalyze the attachment of polyu-fying all of these activators and substrates, and under-
biquitin chains onto lysine residues in target proteins.standing how the Aurora A kinase cooperates with these
Akin to protein biosynthesis in some ways, the reactionproteins and other mitotic regulators, is an exciting chal-
involves up to ten or more repeated cycles of formationlenge for the years to come.
of peptide bonds between the C terminus of ubiquitin
and the epsilon amino groups of lysine side chains. AsClaude Prigent and Re´gis Giet
the polyubiquitin chain grows by approximately 8 kDaCNRS-UMR6061-University of Rennes I
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pears to remain attached to its primary binding site on2 Avenue du Pr Leon Bernard
the E3, the enzyme is faced with the task of accommo-
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dating in its active site a substrate of continuously in-
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creasing size and potentially changing conformation.
The mechanism by which E3 enzymes accomplish thisSelected Reading
complicated task has remained a mystery.
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nents that associate with one of many F-box adaptors
that mediate substrate binding and specificity. Unlike
HECT E3s, SCF complexes do not directly accept acti-
vated ubiquitin from E2s (Seol et al., 1999), thus eliminat-
ing the possibility of growing a chain of activated ubiqui-Dynamic Release of Cdc34
tins prior to attaching it to a substrate lysine. Secondly,
from SCF: The Hand that Rocks rigidity rather than flexibility seems to be required for
SCF function. SCF forms a rigid cradle-like structurethe Cradle
mainly dictated by the banana-shaped CUL1 backbone.
Inserting a flexible linker sequence into CUL1 destroys
SCF function (Zheng et al., 2002).
Polyubiquitylation is a complex but poorly understood At least two more mysteries surround the polyubiqui-
biochemical reaction catalyzed by E3 ubiquitin ligases. tylation mechanism of SCF E3s. (1) Structural modeling
In this issue of Cell, Deffenbaugh et al. provide experi- suggested a large 50 A˚ gap between the substrate
mental support for a model in which the dynamic re- adaptor and the catalytic cysteine of the E2, a distance
lease of the ubiquitin-charged E2 Cdc34 from its pri- difficult to reconcile with catalysis requiring close prox-
mary binding site within the rigid cradle-like SCF E3 imity of the E2 and the substrate (Orlicky et al., 2003;
complex allows for unexpected spatial flexibility to Wu et al., 2003; Zheng et al., 2002). (2) It is not clear
assemble a polyubiquitin chain. how SCF enzymes choose the lysine residue in the target
protein that is to be modified with ubiquitin. Studies with
Ubiquitin-dependent proteolysis is a theme encoun- SCF-TRCP suggested that SCF positions the substrate
-catenin such as to increase the effective concentra-tered in many areas of cellular and molecular biology,
